Source: MISSISSIPPI STATE UNIV submitted to NRP
ALTERNATIVE MYCOPLASMA GALLISEPTICUM (MG) VACCINATION REGIMENS FOR ENHANCEMENT OF PROTECTION AGAINST FIELD STRAIN MG INFECTIONS
Sponsoring Institution
Agricultural Research Service/USDA
Project Status
ACTIVE
Funding Source
Reporting Frequency
Annual
Accession No.
0446667
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Aug 1, 2024
Project End Date
Jul 31, 2029
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
MISSISSIPPI STATE UNIV
(N/A)
MISSISSIPPI STATE,MS 39762
Performing Department
(N/A)
Non Technical Summary
(N/A)
Animal Health Component
30%
Research Effort Categories
Basic
70%
Applied
30%
Developmental
0%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
31132101060100%
Knowledge Area
311 - Animal Diseases;

Subject Of Investigation
3210 - Egg-type chicken, live animal;

Field Of Science
1060 - Biology (whole systems);
Goals / Objectives
To utilize molecular techniques to characterize the immune response of chickens to respiratory diseases in various infection models and their associated interventions.
Project Methods
Mycoplasma gallisepticum (MG) will be used as a model to develop immune surveillance and pathogen phylogenetic tools. Resulting tools will be applied to better understand respiratory infections including MG and its co-infections as well as the efficacy of novel control methods. Molecular lab techniques will be used to develop high throughput methods to evaluate changes in immune gene expression. Developed methods will be used to determine the immune response of commercial birds to respiratory infections. Birds will be infected with a respiratory pathogen, such as MG or Avian Pathogenic Escherichia coli (APEC), in the presence or absence of an environmental stressor (e.g. heat stress, ammonia stress, co-infection, etc.) or intervention (e.g. vaccine, novel antibiotic alternatives, etc.).